Funding opportunities
228 live opportunities from Grants.gov, NIH, NSF, and more.
Chemistry & Materials× remove
- postedgrants.gov
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) ThreatsNational Institutes of HealthRFA-AI-27-014forecastedgrants.gov
- NSF-DFG Lead Agency Opportunity in Chemistry and Chemical Process and Transport SystemsU.S. National Science Foundation25-537postedgrants.gov
- Chemical Evolution of the Solid Earth and VolcanologyU.S. National Science Foundation25-516postedgrants.gov
- A Novel Combinatorial Therapy Targeting Neuroplasticity to Promote FunctionalRecovery in Chronic Spinal Cord InjuryVeterans AffairsRD-01-MRA closes 5/31/2031activenih
- Development of Antibody Chelator Conjugates for Targeted Radionuclide TherapyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $648,992activenih
- Development of novel RPS23 inhibitors for the treatment of leukemiaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $688,012activenih
- Promoting Functional Neuromuscular Regeneration Following Chronic VML in Aged MiceNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 5/31/2031up to $543,417activenih
- Dissecting mechanisms by which mRNA vaccines encoding nontumor antigens initiate antitumor immunityNational Cancer InstitutePA-24-182 closes 5/31/2031up to $136,270activenih
- Regulation of de novo nucleotide synthesis and Glioblastoma response to radiochemotherapyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $656,469activenih
- Natural Products Magnetic Resonance Database (NP-MRD) Phase IINational Center for Complementary and Integrative HealthRFA-AT-24-007 closes 5/31/2031up to $478,106activenih
- Characterizing and therapeutically targeting pH-regulatory mechanisms in the perivascular and infiltrating niches of glioblastoma using amine CEST-EPI and a novel treatment platformNational Cancer InstitutePAR-25-081 closes 5/31/2031up to $640,597activenih
- Initiative for Maximizing Student Development (IMSD) (T32) at Rutgers University-NewarkNational Institute of General Medical SciencesPAR-24-031 closes 5/31/2031up to $581,440activenih
- The MYC Transcription Factor Network: Elucidating Oncogenic and Tumor Suppressive PathwaysNational Cancer InstitutePA-25-301 closes 5/31/2031up to $692,368activenih
- Bioinformatics guided synthesis of novel antibiotics from previously inaccessible microbial dark matterNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $798,670activenih
- Non-canonical functions of the mitochondrial fission protein Drp1 in ovarian cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $638,771activenih
- Multifunctional nanoparticles for improved immunotherapy of melanomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $640,113activenih
- Untangling the Inner Workings of the Mycobacterial Cell EnvelopeNational Institute of General Medical SciencesPAR-22-180 closes 5/31/2031up to $432,892activenih
- Creating cancer-specific genotoxicity by targeting Cas9 nickase to focal gene amplificationsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $622,611activenih
- Reframing BRCA1 Function: A Coordinator of Lagging Strand SynthesisNational Cancer InstitutePA-25-301 closes 5/31/2031up to $469,628activenih
- Developing next-generation mass spectrometric platforms for molecular cartography of the cellular membranesNational Institute of General Medical SciencesPAR-22-180 closes 5/31/2031up to $304,970activenih
- Second-generation new-chemical-entity nanomedicine to target treatment resistance in pancreatic cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $667,482activenih
- Immune reprogramming with bioengineered scaffolds for the treatment of biofilm infectionNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $762,758activenih
- Causal Machine Learning and Trial Emulation for Precision Cardiovascular Risk Stratification in Obstructive Sleep Apnea (CLARITY-OSA)National Heart Lung and Blood InstitutePA-24-176 closes 5/31/2031up to $170,892activenih
- Bacterial modulation of host metabolism and immunity during infectionNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $583,822activenih
Page 1 of 10